Evidence map›Paper›PMID 35788376›Full record

ReviewJournal of the National Cancer Institute. Monographs2022

Health Economics Research in Primary Prevention of Cancer: Assessment, Current Challenges, and Future Directions.

Donatus U Ekwueme, Michael T Halpern, Harrell W Chesson, Mahima Ashok, Jeffrey Drope, Young-Rock Hong, Michael Maciosek, Michael F Pesko, Donald S Kenkel

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of the National Cancer Institute. Monographs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cancer prevention: past challenges and future directions.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  5. Article
  6. Causal Estimation of Long-term Intervention Cost-effectiveness Using Genetic Instrumental Variables: An Application to Cancer.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Article
  7. Cancer Health Economics Research: The Future Is Now.Journal of the National Cancer Institute. Monographs · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Donatus U EkwuemeDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Michael T HalpernHealthcare Delivery Research Program, National Cancer Institute, Bethesda, MD, USA.
Harrell W ChessonDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mahima AshokHealth Transformation & Network Management, Blue Shield of California, Oakland, CA, USA.
Jeffrey DropeHealth Policy and Administration Division of the School of Public Health at University of Illinois, Chicago, Chicago, IL, USA.
Young-Rock HongDepartment of Health Service Research, Management and Policy, University of Florida, Gainesville, FL, USA.
Michael MaciosekHealthPartners Institute, Minneapolis, MN, USA.
Michael F PeskoDepartment of Economics, Georgia State University, Atlanta, GA, USA.
Donald S KenkelDepartment of Economics, Cornell University, Ithaca, NY, USA.
Centers for Disease Control and Prevention · USCornell University · USGeorgia State University · USHealthPartners · USNational Cancer Institute · USUniversity of Florida Health · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past 2 decades, the demand for information on health economics research to guide health care decision making has substantially increased. Studies have provided evidence that eliminating or reducing tobacco use; eating a healthy diet, including fruit and vegetables; being physically active; reducing alcohol consumption; avoiding ultraviolet radiation; and minimizing exposure to environmental and occupational carcinogenic agents should substantially reduce cancer incidence in the population. The benefits of these primary prevention measures in reducing cancer incidence are not instantaneous. Therefore, health economics research has an important role to play in providing credible information to decision makers on the health and economic benefits of primary prevention. This article provides an overview of health economics research related to primary prevention of cancer. We addressed the following questions: 1) What are the gaps and unmet needs for performing health economics research focused on primary prevention of cancer? 2) What are the challenges and opportunities to conducting health economics research to evaluate primary prevention of cancer? and 3) What are the future directions for enhancing health economics research on primary prevention of cancer? Modeling primary prevention of cancer is often difficult given data limitations, long delays before the policy or intervention is effective, possible unintended effects of the policy or intervention, and the necessity of outside expertise to understand key inputs or outputs to the modeling. Despite these challenges, health economics research has an important role to play in providing credible information to decision makers on the health and economic benefits of primary prevention of cancer.

Indexed as

NeoplasmsUltraviolet RaysEconomics, MedicalHumansPrimary PreventionTobacco Use

Identifiers

PMID35788376
PMCPMC9609253
OpenAlexW4225760767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.